Weiying Zhou

5PUBLICATIONS
6CO-AUTHORS
Molecular targetsMedical biochemistry - inorganic elements and compoundsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 13, 2026
Discovery of ZJC-11 as a Novel Selective CDK7 Inhibitor for Treating Triple-Negative Breast Cancer by Inducing Cell Senescence.

|May 03, 2025
Mechanisms underlying seizures and hypothermia during busulphan administration.

Ibrahim El-Serafi, Sofia Berglund, Fadwa BenKessou

|Aug 07, 2024
TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway.

Gang Wang, Yuanli Wu, Yue Su

|Oct 27, 2023
CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification.

Gang Wang, Bo Chen, Yue Su

|Jan 11, 2022
Endoplasmic reticulum stress inhibits AR expression via the PERK/eIF2α/ATF4 pathway in luminal androgen receptor triple-negative breast cancer and prostate cancer.

Xiaoli Li, Duanfang Zhou, Yongqing Cai

Pageof 1

Frequent Collaborators

1 joint publications

Ibrahim El-Serafi

1 joint publications

Matthijs C Dorst

1 joint publications

Manuchehr Abedi-Valugerdi

1 joint publications

Wenyi Zheng